Kellerhals Carrard advised AccorInvest on Swiss legal aspects of its financial restructuring. The AccorInvest group is a leading hotel owner and operator in Europe, operating 862 hotels in 28 countries worldwide, under renowned brands including Sofitel, Pullman,
MLL assisted the Dutch private equity firm Nimbus and its portfolio company Bontexgeo in the acquisition of the Swiss company Stratex. The team was led by Mona Stephenson (Partner, M&A – pictured) and included
Froriep have accompanied Seba Bank in the launch of the Exchange Traded Products Program of SA1 and has advised on setting up a comprehensive program for cryptocurrency linked ETPs. The ETPs allow investors to participate
The European Investment Bank (EIB), the lending arm of the European Union, and BioVersys, a privately-owned clinical-stage pharmaceutical company developing treatments for multidrug-resistant bacterial infections, announced the signing of a EUR 20 million venture debt transaction.
ISS, a global leading facility services provider, has agreed to sell its Swiss subsidiary ISS Kanal Services to KLAR Partners, a pan-European investment firm with a focus on investments in business services and industrial sectors,
Unsere Champions, a successful operator of day nurseries and kindergartens in southern Germany, acquired, for the first time, various childcare facilities in the German-speaking part of Switzerland from private sellers. Vischer advised Unsere Champions on
Grünenthal announced the acquisition of Mestex through the purchase of all of its shares and outstanding options. Mestex is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the
MLL advised and represented an internationally renowned Swiss private bank successfully in an employment dispute concerning a claimed bonus. The dispute concerned a bonus claim raised by a former high ranking employee of the private
PostFinance acquires the e-invoicing business from SIX Paynet, one of Switzerland’s leading e-invoicing providers. The purchase was structured as a bulk asset transfer under the Merger Act and completed on 1 April 2021. It includes the
CeQur, a Swiss medical device company, announced the close of an oversubscribed $115 million equity financing. The company will use the funds to advance commercial plans for CeQur Simplicity, including market development activities, a phased commercial
